Viewing Study NCT01668667


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-01-25 @ 12:42 AM
Study NCT ID: NCT01668667
Status: COMPLETED
Last Update Posted: 2021-05-24
First Post: 2012-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
Sponsor: XenoPort, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Restless Legs Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gabapentin enacarbil View
None Horizant View